Patents by Inventor Ilia Vinogradov

Ilia Vinogradov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8383058
    Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: February 26, 2013
    Assignee: Home Access Health Corporation
    Inventors: Ilia Vinogradov, Michael Wandell, Barbara Godsey
  • Patent number: 8211703
    Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: July 3, 2012
    Assignee: Home Access Health Corporation
    Inventors: Michael Wandell, Ilia Vinogradov
  • Publication number: 20120064555
    Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
    Type: Application
    Filed: November 22, 2011
    Publication date: March 15, 2012
    Applicant: HOME ACCESS HEALTH CORPORATION
    Inventors: Michael Wandell, Ilia Vinogradov
  • Patent number: 8080425
    Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
    Type: Grant
    Filed: December 24, 2008
    Date of Patent: December 20, 2011
    Assignee: Home Access Health Corporation
    Inventors: Ilia Vinogradov, Michael Wandell
  • Publication number: 20100010373
    Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
    Type: Application
    Filed: September 22, 2009
    Publication date: January 14, 2010
    Applicant: HOME ACCESS HEALTH CORPORATION
    Inventors: Michael Wandell, Ilia Vinogradov, Barbara Godsey
  • Patent number: 7611670
    Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: November 3, 2009
    Assignee: Home Access Health Corporation
    Inventors: Michael Wandell, Ilia Vinogradov, Barbara Godsey
  • Patent number: 7569184
    Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
    Type: Grant
    Filed: November 5, 2004
    Date of Patent: August 4, 2009
    Assignee: Home Access Health Corporation
    Inventors: Michael Wandell, Ilia Vinogradov, Barbara Godsey, Troy Bervig
  • Publication number: 20090104636
    Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
    Type: Application
    Filed: December 24, 2008
    Publication date: April 23, 2009
    Applicant: HOME ACCESS HEALTH CORPORATION
    Inventors: Michael Wandell, Ilia Vinogradov
  • Patent number: 7479392
    Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: January 20, 2009
    Assignee: Home Access Health Corporation
    Inventors: Michael Wandell, Ilia Vinogradov
  • Publication number: 20070208275
    Abstract: Disclosed is a fluid collection device that comprises a housing having a normally obverse fluid receiving side and an opposing side. The fluid receiving side has an aperture for receiving a fluid and permitting deposition of the fluid into a fluid collector. The fluid collector is normally inclined to permit inclined fluid flow away from the aperture. Also disclosed is a kit that includes the fluid collection device, and various methods for use of the fluid collection device.
    Type: Application
    Filed: March 1, 2006
    Publication date: September 6, 2007
    Applicant: Home Access Health Corporation
    Inventors: Ilia Vinogradov, Tracey Powell, John Steck
  • Publication number: 20050130310
    Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
    Type: Application
    Filed: November 12, 2003
    Publication date: June 16, 2005
    Applicant: Home Access Health Corporation
    Inventors: Michael Wandell, Ilia Vinogradov, Barbara Godsey
  • Publication number: 20040018484
    Abstract: Disclosed is a method for testing a modified specimen such as a dried blood spot, plasma or serum specimen, for an analyte of interest, such as cholesterol. In accordance with the disclosed subject matter, the level of the analyte of interest in the medium from which the modified specimen was obtained (e.g., from a patient's blood) is determined based on the level of an analyte in a solution formed from the modified specimen and on the level of at least one normalizing analyte. The analyte and normalizing analyte each may be an ion, compound, biochemical entity, or property of the specimen. Also disclosed are a fluid collector and a fluid collection device.
    Type: Application
    Filed: April 23, 2003
    Publication date: January 29, 2004
    Applicant: Home Access Health Corporation
    Inventors: Michael Wandell, Ilia Vinogradov